Aprocitentan in Hypertension Management

Introduction: Hypertension is a chronic medical condition characterized by persistently elevated blood pressure, increasing the risk of cardiovascular diseases, stroke, and kidney complications.

Background: Uncontrolled hypertension remains a major global health concern, particularly among patients who do not achieve adequate blood pressure control with conventional antihypertensive medications.

Study Objective: To evaluate the efficacy and safety of aprocitentan in managing hypertension through a systematic review and meta-analysis.

Mechanism of Action: Examine how aprocitentan, a dual endothelin receptor antagonist, helps reduce blood pressure by blocking endothelin-mediated vasoconstriction.

Efficacy: Assess the effectiveness of aprocitentan in reducing office and ambulatory blood pressure measurements.

Safety and Adverse Effects: Evaluate potential adverse effects, including fluid retention, peripheral edema, anemia, and other treatment-related complications.

Dosage and Administration: Review the recommended dosage, administration methods, treatment duration, and dose-related outcomes.

Comparative Analysis: Compare aprocitentan with placebo and other antihypertensive treatments in terms of blood pressure reduction and safety.

Clinical Outcomes: Assess improvements in blood pressure control, treatment response, long-term effectiveness, and cardiovascular risk factors.

Challenges and Limitations: Examine limitations such as adverse effects, treatment adherence, clinical trial variations, limited long-term evidence, and patient-specific responses.

Conclusion: Understanding the efficacy and safety of aprocitentan is essential for determining its potential role in hypertension management, particularly among patients with uncontrolled blood pressure.